This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

SOLVD - prevention arm

Authoring team

This multicentre, randomised, double-blind, placebo-controlled trial enrolled 4228 patients with reduced left ventricular function (ejection fraction <35%) but without symptomatic heart failure.

The addition of enalapril to the conventional heart failure treatment resulted in a significant 37% decrease in the incidence of heart failure.

Reference:

  • SOLVD Investigators. (1992). N Engl J Med. 327, 685-691.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.